FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Hoel

Research Profile

Concepts & Ideas

Chemicals & Drugs

Carcinogens

Disorders

Geographic Areas

Living Beings

Mouse

Activities & Behaviors

Co-author Network

Publications

TOP 3
Dulaney A Wilson; Joseph H Diel; David G Hoel
Lung fibrosis and lung cancer incidence in beagle dogs that inhaled 238PuO2 or 239PuO2.
David J Jollow; James V Bruckner; David C McMillan; Jeffrey W Fisher; David G Hoel; Lawrence C Mohr
Trichloroethylene risk assessment: a review and commentary.
Katharine M McGreevy; Stuart R Lipsitz; Jeffrey A Linder; Eric Rimm; David G Hoel
Using median regression to obtain adjusted estimates of central tendency for skewed laboratory and epidemiologic data.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Hoel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Dulaney A Wilson; Joseph H Diel; David G Hoel
Lung fibrosis and lung cancer incidence in beagle dogs that inhaled 238PuO2 or 239PuO2.
Health physics 2009;96(4):493-503.
2009: David J Jollow; James V Bruckner; David C McMillan; Jeffrey W Fisher; David G Hoel; Lawrence C Mohr
Trichloroethylene risk assessment: a review and commentary.
Critical reviews in toxicology 2009;39(9):782-97.
2009: Katharine M McGreevy; Stuart R Lipsitz; Jeffrey A Linder; Eric Rimm; David G Hoel
Using median regression to obtain adjusted estimates of central tendency for skewed laboratory and epidemiologic data.
Clinical chemistry 2009;55(1):165-9.
2008: M P Little; David G Hoel; J Molitor; J D Boice; R Wakeford; C R Muirhead
New models for evaluation of radiation-induced lifetime cancer risk and its uncertainty employed in the UNSCEAR 2006 report.
Radiation research 2008;169(6):660-76.
2007: A S Adelman; Frank D Groves; K O'Rourke; D Sinha; Thomas C Hulsey; Andrew B Lawson; D Wartenberg; David G Hoel
Residential mobility and risk of childhood acute lymphoblastic leukaemia: an ecological study.
British journal of cancer 2007;97(1):140-4.
2007: P J Baker; David G Hoel
Meta-analysis of standardized incidence and mortality rates of childhood leukaemia in proximity to nuclear facilities.
European journal of cancer care 2007;16(4):355-63.
2007: Richard Reiss; Elizabeth L Anderson; Carroll E Cross; George M Hidy; David G Hoel; Roger McClellan; Suresh H Moolgavkar
Evidence of health impacts of sulfate-and nitrate-containing particles in ambient air.
Inhalation toxicology 2007;19(5):419-49.
2007: Katharine M McGreevy; Brian D Hoel; Stuart R Lipsitz; David G Hoel
Impact of nutrients on insulin-like growth factor-I, insulin-like growth factor binding protein-3 and their ratio in African American and white males.
Public health nutrition 2007;10(1):97-105.
2006: N D Priest; David G Hoel; P N Brooks
Relative toxicity of chronic irradiation by 45Ca beta particles and 242Cm alpha particles with respect to the production of lung tumors in CBA/Ca mice.
Radiation research 2006;166(5):782-93.
2006: David G Hoel
Ionizing radiation and cardiovascular disease.
Annals of the New York Academy of Sciences 2006;1076():309-17.
2006: Apryl Bronley-DeLancey; David C McMillan; JoEllyn M McMillan; David J Jollow; Lawrence C Mohr; David G Hoel
Application of cryopreserved human hepatocytes in trichloroethylene risk assessment: relative disposition of chloral hydrate to trichloroacetate and trichloroethanol.
Environmental health perspectives 2006;114(8):1237-42.
2006: Katharine M McGreevy; Keith Rodgers; Stuart R Lipsitz; Nabil Bissada; David G Hoel
Impact of race and baseline PSA on longitudinal PSA.
International journal of cancer. Journal international du cancer 2006;118(7):1773-6.
2005: Toshio Makie; David Adcock; Daniel T Lackland; David G Hoel
Pulmonary abnormalities associated with occupational exposures at the Savannah River Site.
American journal of industrial medicine 2005;48(5):365-72.
2005: Katharine M McGreevy; Brian D Hoel; Stuart R Lipsitz; Nabil Bissada; David G Hoel
Racial and anthropometric differences in plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein-3.
Urology 2005;66(3):587-92.
2005: Thomas B Starr; Jay I Goodman; David G Hoel
Uses of benchmark dose methodology in quantitative risk assessment.
Regulatory toxicology and pharmacology : RTP 2005;42(1):1-2.
2004: C W Heath; P D Bond; David G Hoel; C B Meinhold
Residential radon exposure and lung cancer risk: commentary on Cohen's county-based study.
Health physics 2004;87(6):647-55; discussion 656-8.
2003: Gizelle S Baker; David G Hoel
Corrections in the atomic bomb data to examine low dose risk.
Health physics 2003;85(6):709-20.
2003: William T Creasman; David G Hoel; Philip J DiSaia
WHI: Now that the dust has settled: a commentary.
American journal of obstetrics and gynecology 2003;189(3):621-6.
2003: Joyce S Nicholas; GC Butler; S Davis; E Bryant; David G Hoel; Lawrence C Mohr
Stable chromosome aberrations and ionizing radiation in airline pilots.
Aviation, space, and environmental medicine 2003;74(9):953-6.
2002: Katharine M McGreevy; Lisa F Baron; David G Hoel
Clinical breast examination practices among women undergoing screening mammography.
Radiology 2002;224(2):555-9.
2002: M K Schubauer-Berigan; G Donald Frey; Lisa F Baron; David G Hoel
Mammography dose in relation to body mass index, race, and menopausal status.
Radiation protection dosimetry 2002;98(4):425-32.
2002: M K Schubauer-Berigan; Lisa F Baron; G Donald Frey; David G Hoel
Breast dose variability in a bi-racial population undergoing screening mammography.
Radiation protection dosimetry 2002;98(4):417-24.
2001: Joyce S Nicholas; GC Butler; Daniel T Lackland; G S Tessier; Lawrence C Mohr; David G Hoel
Health among commercial airline pilots.
Aviation, space, and environmental medicine 2001;72(9):821-6.
2000: Joyce S Nicholas; GC Butler; Daniel T Lackland; W C Hood; David G Hoel; Lawrence C Mohr
Flight deck magnetic fields in commercial aircraft.
American journal of industrial medicine 2000;38(5):548-54.
2000: Tomas Radivoyevitch; David G Hoel
Biologically-based risk estimation for radiation-induced chronic myeloid leukemia.
Radiation and environmental biophysics 2000;39(3):153-9.
1999: Tomas Radivoyevitch; David G Hoel
Modeling the low-LET dose-response of BCR-ABL formation: predicting stem cell numbers from A-bomb data.
Mathematical biosciences 1999;162(1-2):85-101.
1999: Bernd Grosche; Daniel T Lackland; Lawrence C Mohr; J Dunbar; Joyce S Nicholas; W Burkart; David G Hoel
Leukaemia in the vicinity of two tritium-releasing nuclear facilities: a comparison of the Kruemmel Site, Germany, and the Savannah River Site, South Carolina, USA.
Journal of radiological protection : official journal of the Society for Radiological Protection 1999;19(3):243-52.
1999: Gregg E Dinse; D M Umbach; A J Sasco; David G Hoel; D L Davis
Unexplained increases in cancer incidence in the United States from 1975 to 1994: possible sentinel health indicators?
Annual review of public health 1999;20():173-209.
1998: Joyce S Nicholas; Daniel T Lackland; GC Butler; Lawrence C Mohr; J B Dunbar; W T Kaune; B Grosche; David G Hoel
Cosmic radiation and magnetic field exposure to airline flight crews.
American journal of industrial medicine 1998;34(6):574-80.
1998: Joyce S Nicholas; Daniel T Lackland; M Dosemeci; Lawrence C Mohr; J B Dunbar; B Grosche; David G Hoel
Mortality among US commercial pilots and navigators.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 1998;40(11):980-5.
1998: David G Hoel; P Li
Threshold models in radiation carcinogenesis.
Health physics 1998;75(3):241-50.
1998: Paul Nietert; Susan E Sutherland; Richard M Silver; Janardan P Pandey; Rebecca G Knapp; David G Hoel; M Dosemeci
Is occupational organic solvent exposure a risk factor for scleroderma?
Arthritis and rheumatism 1998;41(6):1111-8.
1998: Tomas Radivoyevitch; David G Hoel; Philip Hahnfeldt; Rainer K Sachs
Size distributions of misrejoining DNA fragments in irradiated cells.
Mathematical biosciences 1998;149(2):107-36.
1998: Tomas Radivoyevitch; David G Hoel; A M Chen; Rainer K Sachs
Misrejoining of double-strand breaks after X irradiation: relating moderate to very high doses by a Markov model.
Radiation research 1998;149(1):59-67.
1998: Tomas Radivoyevitch; David G Hoel; Philip Hahnfeldt; B Rydberg; Rainer K Sachs
Recent data obtained by pulsed-field gel electrophoresis suggest two types of double-strand breaks.
Radiation research 1998;149(1):52-8.
1995: David G Hoel
Ionizing radiation and cancer prevention.
Environmental health perspectives 1995;103 Suppl 8():241-3.
1994: D L Davis; G E Dinse; David G Hoel
Decreasing cardiovascular disease and increasing cancer among whites in the United States from 1973 through 1987. Good news and bad news.
JAMA : the journal of the American Medical Association 1994;271(6):431-7.
1994: H Mori; T Nakamura; M Mine; H Kondo; Y Okumura; David G Hoel
Early mortality rate of atomic bomb survivors based on House Reconstruction Survey.
International journal of radiation biology 1994;65(2):267-75.
1994: David G Hoel; Christopher Portier
Nonlinearity of dose-response functions for carcinogenicity.
Environmental health perspectives 1994;102 Suppl 1():109-13.
1993: David G Hoel
Questions about radiation and risk estimates that remain after BEIR V.
Radiation research 1993;136(1):137-9.
1993: D L Davis; H Leon Bradlow; M Wolff; T Woodruff; David G Hoel; H Anton-Culver
Medical hypothesis: xenoestrogens as preventable causes of breast cancer.
Environmental health perspectives 1993;101(5):372-7.
1993: David G Hoel; E Ron; R Carter; K Mabuchi
Influence of death certificate errors on cancer mortality trends.
Journal of the National Cancer Institute 1993;85(13):1063-8.
1993: V A Fung; James Huff; E K Weisburger; David G Hoel
Predictive strategies for selecting 379 NCI/NTP chemicals evaluated for carcinogenic potential: scientific and public health impact.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1993;20(4):413-36.
1993: D L Davis; A Blair; David G Hoel
Agricultural exposures and cancer trends in developed countries.
Environmental health perspectives 1993;100():39-44.
1993: C Portier; A Tritscher; M Kohn; C Sewall; G Clark; L Edler; David G Hoel; George W Lucier
Ligand/receptor binding for 2,3,7,8-TCDD: implications for risk assessment.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1993;20(1):48-56.
1992: D L Davis; David G Hoel
Tobacco-associated deaths.
Lancet 1992;340(8820):666.
1992: G E Dinse; David G Hoel
Exploring time trends in cancer incidence.
Cancer causes & control : CCC 1992;3(5):409-17.
1992: Y Shimizu; H Kato; W J Schull; David G Hoel
Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 3. Noncancer mortality based on the revised doses (DS86).
Radiation research 1992;130(2):249-66.
1992: G W Lucier; C L Thompson; David G Hoel
Omeprazole, cytochrome P450, and chemical carcinogenesis.
Gastroenterology 1992;102(5):1823-4.
1992: David G Hoel; D L Davis; Anthony B Miller; E J Sondik; A J Swerdlow
Trends in cancer mortality in 15 industrialized countries, 1969-1986.
Journal of the National Cancer Institute 1992;84(5):313-20.
1992: Walter W Piegorsch; G J Carr; Christopher Portier; David G Hoel
Concordance of carcinogenic response between rodent species: potency dependence and potential underestimation.
Risk analysis : an official publication of the Society for Risk Analysis 1992;12(1):115-21.
1992: D L Davis; David G Hoel
Figuring out cancer.
International journal of health services : planning, administration, evaluation 1992;22(3):447-53.
1992: James Huff; David G Hoel
Perspective and overview of the concepts and value of hazard identification as the initial phase of risk assessment for cancer and human health.
Scandinavian journal of work, environment & health 1992;18 Suppl 1():83-9.
1991: James A Swenberg; David G Hoel; P N Magee
Mechanistic and statistical insight into the large carcinogenesis bioassays on N-nitrosodiethylamine and N-nitrosodimethylamine.
Cancer research 1991;51(23 Pt 2):6409-14.
1991: David G Hoel
A balanced approach to risk assessment.
Toxicology and industrial health 1991;7(5-6):305-11.
1991: Frederick de Serres; David G Hoel
Objectives of the collaborative study on the genetic toxicology of 2-amino-N6-hydroxyadenine: an exercise in genetic risk assessment.
Mutation research 1991;253(1):1-3.
1991: D L Davis; A Ahlbom; David G Hoel; C Percy
Is brain cancer mortality increasing in industrial countries?
American journal of industrial medicine 1991;19(4):421-31.
1990: David G Hoel
Assumptions of the HERP Index.
Risk analysis : an official publication of the Society for Risk Analysis 1990;10(4):623-4; discussion 629-33.
1990: D L Davis; David G Hoel; J Fox; A Lopez
International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA.
Lancet 1990;336(8713):474-81.
1990: David G Hoel; G E Dinse
Using mortality data to estimate radiation effects on breast cancer incidence.
Environmental health perspectives 1990;87():123-9.
1990: D L Davis; David G Hoel; J Fox; A D Lopez
International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the United States.
Annals of the New York Academy of Sciences 1990;609():5-48.
1990: D L Davis; David G Hoel; C Percy; A Ahlbom; J Schwartz
Is brain cancer mortality increasing in industrial countries?
Annals of the New York Academy of Sciences 1990;609():191-204.
1990: D L Davis; David G Hoel
Trends in cancer mortality in industrial countries. Introduction.
Annals of the New York Academy of Sciences 1990;609():ix-xi.
1990: Christopher Portier; David G Hoel; Norman L Kaplan; A Kopp
Biologically based models for risk assessment.
IARC scientific publications 1990;(104):20-8.
1989: A John Bailer; David G Hoel
Benzene risk assessments: review and update.
Cell biology and toxicology 1989;5(3):287-95.
1989: A John Bailer; David G Hoel
Metabolite-based internal doses used in a risk assessment of benzene.
Environmental health perspectives 1989;82():177-84.
1988: David G Hoel; J K Haseman; M D Hogan; James Huff; E E McConnell
The impact of toxicity on carcinogenicity studies: implications for risk assessment.
Carcinogenesis 1988;9(11):2045-52.
1988: Walter W Piegorsch; David G Hoel
Exploring relationships between mutagenic and carcinogenic potencies.
Mutation research 1988;196(2):161-75.
1988: Lee G Pedersen; Thomas A Darden; D W Deerfield; M W Anderson; David G Hoel
A theoretical study of the effect of methylation or ethylation at O6-guanine in the structure and energy of DNA double strands.
Carcinogenesis 1988;9(9):1553-62.
1987: David G Hoel
Cancer risk models for ionizing radiation.
Environmental health perspectives 1987;76():121-4.
1987: Christopher Portier; David G Hoel
Issues concerning the estimation of the TD50.
Risk analysis : an official publication of the Society for Risk Analysis 1987;7(4):437-47.
1987: C R Weinberg; K G Brown; David G Hoel
Altitude, radiation, and mortality from cancer and heart disease.
Radiation research 1987;112(2):381-90.
1987: David G Hoel
Radiation risk estimation models.
Environmental health perspectives 1987;75():105-7.
1986: Christopher Portier; J C Hedges; David G Hoel
Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experiments.
Cancer research 1986;46(9):4372-8.
1986: K G Brown; David G Hoel
Statistical modeling of animal bioassay data with variable dosing regimens: example--vinyl chloride.
Risk analysis : an official publication of the Society for Risk Analysis 1986;6(2):155-66.
1986: L S Gold; L Bernstein; J Kaldor; G Backman; David G Hoel
An empirical comparison of methods used to estimate carcinogenic potency in long-term animal bioassays: lifetable vs summary incidence data.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1986;6(2):263-9.
1985: L Bernstein; L S Gold; B N Ames; Malcolm Pike; David G Hoel
Toxicity and carcinogenic potency.
Risk analysis : an official publication of the Society for Risk Analysis 1985;5(4):263-4.
1985: T Yanagawa; David G Hoel
Use of historical controls for animal experiments.
Environmental health perspectives 1985;63():217-24.
1985: David G Hoel
Epidemiology and the inference of cancer mechanisms.
National Cancer Institute monograph 1985;67():199-203.
1985: L Bernstein; L S Gold; B N Ames; Malcolm Pike; David G Hoel
Some tautologous aspects of the comparison of carcinogenic potency in rats and mice.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1985;5(1):79-86.
1984: A H Racine-Poon; David G Hoel
Nonparametric estimation of the survival function when cause of death is uncertain.
Biometrics 1984;40(4):1151-8.
1984: Christopher Portier; David G Hoel
Design of animal carcinogenicity studies for goodness-of-fit of multistage models.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1984;4(6):949-59.
1983: C Portier; David G Hoel
Low-dose-rate extrapolation using the multistage model.
Biometrics 1983;39(4):897-906.
1983: K G Brown; David G Hoel
Multistage prediction of cancer in serially dosed animals with application to the ED01 study.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1983;3(5):470-7.
1983: K G Brown; David G Hoel
Modeling time-to-tumor data: analysis of the ED01 study.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1983;3(5):458-69.
1983: David G Hoel; T Wakabayashi; Malcolm Pike
Secular trends in the distributions of the breast cancer risk factors--menarche, first birth, menopause, and weight--in Hiroshima and Nagasaki, Japan.
American journal of epidemiology 1983;118(1):78-89.
1983: C Portier; David G Hoel
Optimal design of the chronic animal bioassay.
Journal of toxicology and environmental health 1983;12(1):1-19.
1983: Malcolm Pike; M D Krailo; Brian Henderson; J T Casagrande; David G Hoel
'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer.
Nature 1983;303(5920):767-70.
1983: David G Hoel; Norman L Kaplan; M W Anderson
Implication of nonlinear kinetics on risk estimation in carcinogenesis.
Science (New York, N.Y.) 1983;219(4588):1032-7.
1982: H Kato; C C Brown; David G Hoel; W J Schull
Studies of the mortality of A-bomb survivors. Report 7. Mortality, 1950-1978: Part II. Mortality from causes other than cancer and mortality in early entrants.
Radiation research 1982;91(2):243-64.
1982: David G Hoel
Statistical measures of risk.
Drug metabolism reviews 1982;13(5):829-38.
1981: J K Haseman; David G Hoel; R I Jennrich
Some practical problems arising from use of the gamma multihit model for risk estimation.
Journal of toxicology and environmental health 1981;8(3):379-86.
1980: M W Anderson; David G Hoel; Norman L Kaplan
A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: example--vinyl chloride.
Toxicology and applied pharmacology 1980;55(1):154-61.
1980: David G Hoel
Incorporation of background in dose-response models.
Federation proceedings 1980;39(1):73-5.
1979: David G Hoel
Statistical approaches to toxicological data.
Environmental health perspectives 1979;32():267-71.
1979: David G Hoel
Animal experimentation and its relevance to man.
Environmental health perspectives 1979;32():25-30.
1979: J K Haseman; David G Hoel
Statistical design of toxicity assays: role of genetic structure of test animal population.
Journal of environmental pathology and toxicology 1979;2(6):1313-27.
1979: David G Hoel
Sequential methods in genetic risk assessment.
Genetics 1979;92(1 Pt 1 Suppl):s195-8.
1979: J K Haseman; David G Hoel
Statistical design of toxicity assays: role of genetic structure of test animal population.
Journal of toxicology and environmental health 1979;5(1):89-101.
1979: M D Hogan; P Y Chi; David G Hoel; T J Mitchell
Association between chloroform levels in finished drinking water supplies and various site-specific cancer mortality rates.
Journal of environmental pathology and toxicology 1979;2(3):873-87.
1977: H A Guess; David G Hoel
The effect of dose on cancer latency period.
Journal of environmental pathology and toxicology 1977;1(2):279-86.
1976: K S Crump; David G Hoel; C H Langley; R Peto
Fundamental carcinogenic processes and their implications for low dose risk assessment.
Cancer research 1976;36(9 pt.1):2973-9.
1976: David G Hoel
Occupational carcinogenesis. Statistical extrapolation methods for estimating risks from animal data.
Annals of the New York Academy of Sciences 1976;271():418-20.
1975: David G Hoel; D W Gaylor; R L Kirschstein; U Saffiotti; M A Schneiderman
Estimation of risks of irreversible, delayed toxicity.
Journal of toxicology and environmental health 1975;1(1):133-51.
1974: David G Hoel; K S Crump
Estimating the generation-time distribution of an age-dependent branching process.
Biometrics 1974;30(1):125-35.
1972: G E Hook; J R Bend; David G Hoel; J R Fouts; T E Gram
Preparation of lung microsomes and a comparison of the distribution of enzymes between subcellular fractions of rabbit lung and liver.
The Journal of pharmacology and experimental therapeutics 1972;182(3):474-90.
1972: David G Hoel; H E Walburg
Statistical analysis of survival experiments.
Journal of the National Cancer Institute 1972;49(2):361-72.
1972: David G Hoel
A representation of mortality data by competing risks.
Biometrics 1972;28(2):475-88.
1971: David G Hoel; T J Mitchell
The simulation, fitting, and testing of a stochastic cellular proliferation model.
Biometrics 1971;27(1):191-9.